Supplier profile
Bristol-Myers Squibb; S.A.
Every public-sector award we hold for this supplier, across Spain, France, Luxembourg and Portugal, from 28 May 2008 to 30 Sept 2026.
Awards won
306
all time
Attributed value
€398.5m
68 shared, unvalued
Buyers
170
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Centro Hospitalar Lisboa Norte; EPE | 13 | €1.8m |
| Centro Hospitalar Lisboa Norte, EPE | 12 | €2.0m |
| Osakidetza | 10 | €27.1m |
| Corporació Sanitària Parc Taulí | 7 | €2.3m |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 7 | €93.8m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 5 | €3.5m |
| Servicio Madrileño de Salud, Hospital Universitario 12 de Octubre | 5 | €1.9m |
| Centro Hospitalar Lisboa Norte, E. P. E. | 4 | €1.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 4 | €459k |
| Ente Público Hospital Universitario de Fuenlabrada | 4 | €1.5m |
What they win
Awards
Showing 51–75 of 306 awards we hold
- Suministro del principio activo denominado "Luspatercept 25 mg vial polvo inyectable" ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€66kawarded 23 Aug 2024
- Spain – Pharmaceutical products – Acuerdo Marco de suministro (CONTR 2023 0000714922) ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REINA SOFÍAshared awardawarded 20 Aug 2024
- Spain – Pharmaceutical products – Suministro de Plerixafor (DOE), Icatibant (DOE), Paclitaxel (DOE), Ácido zoledrónico (DOE), Cefepima (DOE), Clindamicina (DOE), Ceftazidima (DOE), Ciprofloxacino (DOE) y Capecitabina (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Centralshared awardawarded 10 Aug 2024
- Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2023 0001153871) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.shared awardawarded 8 Aug 2024
- Suministro del principio activo OZANIMOD ↗Gerencia de Servicio Sanitarios de Fuerteventura€34kawarded 17 Jun 2024
- Spain – Pharmaceutical products – PNSPAM 4/24 (CONTR 2024 0000311484) ↗Servicio Andaluz de Salud. Hospital Universitario Reina Sofía.awarded 11 Jun 2024
- Spain – Pharmaceutical products – Suministro CONTR 2024 0000314866 ↗Servicio Andaluz de Salud. Hospital Universitario de Torrecárdenas.shared awardawarded 4 Jun 2024
- Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2023 0001044970) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.shared awardawarded 4 Jun 2024
- Spain – Pharmaceutical products – Suministro de Fedratinib (DOE), Luspatercept (DOE) Y Azacitidina (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€2.0mawarded 30 May 2024
- Spain – Pharmaceutical products – Suministros ( CCA. 6AX64H-) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaénshared awardawarded 1 May 2024
- Spain – Pharmaceutical products – Suministro de fármaco Orencia 250 mg 1 vial PVO + 1 JER SOL ↗Gerencia del Área de Salud de Badajoz€306kawarded 21 Mar 2024
- Suministro de fármaco Orencia 250 mg 1 vial PVO + 1 JER SOL ↗Gerencia del Área de Salud de Badajoz€306kawarded 21 Mar 2024
- Suministro de medicamentos exclusivos para los centros sanitarios dependientes del Servei de Salut de les Illes Balears ↗Servicio de Salud de las Illes Balearsshared awardawarded 26 Jan 2024
- Spain-Valls: Immunosuppressive agents ↗GESTIÓ PIUS HOSPITAL DE VALLS, SAMshared awardawarded 5 Dec 2023
- Spain-Valls: Immunosuppressive agents ↗GESTIÓ PIUS HOSPITAL DE VALLS, SAMshared awardawarded 5 Dec 2023
- Spain-Olot: Immunosuppressive agents ↗FUNDACIÓ HOSPITAL D’OLOT I COMARCAL DE LA GARROTXAshared awardawarded 1 Dec 2023
- Spain-Badalona: Immunosuppressive agents ↗Badalona Serveis Assistencials, SAshared awardawarded 27 Nov 2023
- Spain-Llerena: Antineoplastic agents ↗Gerencia del Área de Salud de Llerena-Zafra€358kawarded 8 Sept 2023
- Spain-Calella: Immunosuppressive agents ↗CORPORACIO DE SALUT DEL MARESME I LA SELVAshared awardawarded 1 Sept 2023
- Spain-Mataró: Immunosuppressive agents ↗Consorci Sanitari del Maresmeshared awardawarded 7 Aug 2023
- Suministro del medicamento Nivolumab 10 mg/ml concentrado para solución para perfusión vial de 10 ml, con destino a los hospitales de Llerena y de Zafra dependientes de la Gerencia del Área de Salud de Llerena-Zafra. ↗Gerencia del Área de Salud de Llerena-Zafra€358kawarded 24 Jul 2023
- Spain-Malaga: Pharmaceutical products ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA€221kawarded 20 Jun 2023
- Spain-L'Hospitalet de Llobregat: Medical equipments, pharmaceuticals and personal care products ↗Consorci Sanitari Integralshared awardawarded 16 Jun 2023
- Spain-L'Hospitalet de Llobregat: Immunosuppressive agents ↗Consorci Sanitari Integralshared awardawarded 7 Jun 2023
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€1.7mawarded 13 Mar 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Bristol Myers Squibb413 awards · £3.3m
- BRISTOL-MYERS SQUIBB S.R.L.124 awards
- Bristol-Myers Squibb AB11 awards
- Bristol Myers Squibb, S. L.4 awards
- BRISTOL-MYERS SQUIBB, S.L.U.2 awards
- Bristol MYERS Squibb SpA2 awards
- Bristol-Myers Squibb (Finland) AB1 award
- Bristol Myers Squibb NV1 award
- Bristol-Myers Squibb Oy Ab1 award
- bristol myers squibb sarl1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.